H.C. Wainwright Upgrades Syros Pharmaceuticals (SYRS) to Buy; 'Turned a Corner'
Tweet Send to a Friend
(Updated - November 4, 2020 7:40 AM EST)(updated to add analyst comments)H.C. Wainwright analyst Andrew Fein upgraded Syros Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
